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Sarcoidosis is an idiopathic disease that most commonly involves the lungs and is characterized by
granulomatous inﬂammation. Bronchiectasis is one pulmonary manifestation of sarcoidosis, although it
is almost always observed as traction bronchiectasis in the setting of ﬁbrotic lung disease. A 50-year-old
woman was evaluated for chronic cough and bronchiectasis with a small amount of peripheral upper
lobe honeycombing and no signiﬁcant pulmonary ﬁbrosis or lymphadenopathy. After an extensive
laboratory and imaging evaluation did not identify a cause of her bronchiectasis, bronchoscopy was
performed to assess for primary ciliary dyskinesia and revealed a diffuse cobblestone appearance of the
airway mucosa. Endobronchial biopsies and lymphocyte subset analysis of bronchoalveolar lavage ﬂuid
were consistent with a diagnosis of sarcoidosis. We believe endobronchial sarcoidosis should be included
in the differential diagnosis of patients presenting with bronchiectasis.
Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Sarcoidosis is an idiopathic granulomatous disease that can
affect every organ system, most commonly the lungs, which are
involved in over 90% of cases [1,2]. There are numerous clinical
manifestations of pulmonary sarcoidosis, including pulmonary
nodules, ﬁbrotic lung disease, airway hyperreactivity, mucosal
nodules and plaques, bronchostenosis, and bronchiectasis [3]. The
most common cause of bronchiectasis in sarcoidosis is traction
bronchiectasis and has been reported in up to 40% of patients with
ﬁbrotic lung disease due to sarcoidosis [4].We present a rare case of
diffuse bronchiectasis due to endobronchial sarcoidosis.1.1. Case report
A 50-year-old-womanwith allergic rhinitis and infertility (three
attempts at in vitro fertilization were unsuccessful) was referred to
pulmonary clinic for bronchiectasis and chronic cough. She re-
ported several years of a chronic cough productive of pale yellow
sputum, as well as recurrent respiratory and sinus infections that
would respond to oral antibiotics. She denied any smoking historyes).
access article under the CC BY-NCand occupational or environmental exposures, and her medications
included gabapentin, levocetirizine, and intranasal ﬂuticasone. Her
vital signs and physical exam were within normal limits. Pulmo-
nary function tests revealed an isolated reduction in the DLCO to
66% predicted. A high-resolution chest CT demonstrated diffuse
upper lobe-predominant bronchiectasis and a small amount of
peripheral honeycombing in both upper lobes and scattered tree-
in-bud and ground glass opacities (Fig. 1); the bronchiectasis and
peripheral honeycombing had progressed slightly compared to a
chest CT performed eight years prior and there was no signiﬁcant
pulmonary ﬁbrosis or hilar or mediastinal lymphadenopathy.
A laboratory evaluation was initiated in an attempt to identify
the cause of her bronchiectasis. Screening tests for connective tis-
sue disease including rheumatoid factor, anti-CCP antibody, anti-
nuclear antibody, anti-Smith antibody, anti-SSA and SSB antibodies,
and anti-RNP antibody were all negative. The serum IgE was
elevated to 187 IU/mL, but Aspergillus precipitins and serum-
speciﬁc IgE antibodies to Aspergillus fumigatus were negative.
Quantitative immunoglobulins and IgG subclasses were normal. A
sweat chloride test was negative and a CFTR genemutation analysis
was normal.
In order to obtain targeted samples for culture and test for
primary ciliary dyskinesia, a bronchoscopy was performed. Endo-
bronchial biopsies of the main carina were collected with forceps
and brushes for transmission electron microscopy, which showed-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. a - HRCT Axial. b - HRCT Coronal.
Fig. 2. a - Right Lung Bronchoscopy. b - Left Lung Bronchoscopy.
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mycobacterial cultures obtained from bronchoalveolar lavage (BAL)
ﬂuid and brushes of the right upper lobe grew no organisms.
Airway survey unexpectedly revealed diffuse cobblestoning of the
endobronchial mucosa distal to the secondary carinas (Fig. 2), so
additional endobronchial forceps biopsies and transbronchial bi-
opsies of the right upper lobewere collected for histopathology and
the BAL ﬂuid was sent for lymphocyte subset analysis. The CD4:CD8
ratio of the BAL ﬂuid returned elevated at 8.9 and the endobron-
chial biopsies showed well-formed, non-caseating granulomasFig. 3. a - Endobronchial Granulowith chronic inﬂammation and giant cells with Schaumann bodies
(Fig. 3). Given the diffuse endobronchial cobblestoning, elevated
BAL CD4:CD8 ratio, non-caseating granulomas with Schaumann
bodies, and negative cultures, she was diagnosed with sarcoidosis.
2. Discussion
The non-caseating granuloma is the histopathologic hallmark of
sarcoidosis and in one prospective study of 34 patients with sus-
pected sarcoidosis was found on endobronchial biopsy in 61.8% ofmas. b - Schaumann Bodies.
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patients with an abnormal-appearing airway mucosa, but still
revealed granulomas in 30.0% of patients with a normal-appearing
airway mucosa [5]. Schaumann bodies, also known as conchoidal
bodies, are concentric calciﬁcations containing calcium oxalate
crystals that are commonly seen in sarcoid granulomas [6,7],
although they are not pathognomonic of the diagnosis [8].
When bronchiectasis is described in patients with sarcoidosis,
the pathogenesis is almost exclusively attributed to traction bron-
chiectasis from ﬁbrotic lung disease [3,9e12]. Several other
mechanisms have been described, however, including chronic or
recurrent infections [13] and extrinsic airway compression from
enlarged lymph nodes causing a “middle lobe syndrome.” [14,15]
Endobronchial sarcoidosis has been reported as a cause of bron-
chiectasis; however, this is typically in association with bronchos-
tenosis due to granulomatous inﬂammation and edema, an
endobronchial mass, or scarring [9,13,16].
This case is unique due to the presence of diffuse bronchiectasis
without any signiﬁcant ﬁbrotic lung disease, bronchostenosis, or
lymphadenopathy in a patient with endobronchial sarcoidosis. In
this patient, bronchiectasis may have developed as the result of
extensive granulomatous inﬂammation that caused bronchial wall
damage [9,16]. Since the majority of cases of non-cystic ﬁbrosis
bronchiectasis are reported to be idiopathic [17,18], we suggest that
bronchoscopy with endobronchial biopsy be considered as part of
the diagnostic evaluation in these patients to assess for possible
endobronchial sarcoidosis.
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